Researchers sought to determine whether the CAR-T therapy volamcabtagene durzigedleucel (CTX130) would be effective in patients with T-cell lymphoma.

Acitretin (Soriatane ®) and bexarotene are the two orally available retinoids used most commonly for treating MF. These drugs are derivatives of vitamin A and are in the same class of agents as ...

The inflammation and abnormal scaling, flaking, and cracking of the upper layers of the skin in patients with CTCL leads to considerable itching and discomfort. Generally this can be controlled ...

including the most common subtypes mycosis fungoides and Sézary syndrome, were given DD-cxdl for five consecutive days every 21 days. Roughly 36% of patients responded to the treatment ...

The next donor recruitment drives for the Marshall's Match campaign are being held this weekend - with one taking place at ...

These innovations are expanding treatment options, improving patient quality of life, and fueling market growth in the mycosis fungoides landscape. Developments in Early Detection and Diagnostic ...

Contribute to anilberman/anil09fab development by creating an account on GitHub.

A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter clinical trial published in the Journal of Clinical Oncology.

Skip to content Navigation Menu Toggle navigation ...

New Brunswick chose Poteligeo, often used for mycosis fungoides or Sézary syndrome — two types ... The journal says: Poteligeo is expected to cost about $35,258 in the first treatment cycle. Oxlumo is ...